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Abstract To investigate the retinal nerve fibre layer
(RNFL) changes after an acute attack of phacomor-
phic angle closure. This prospective study involved
ten cases of phacomorphic angle closure that under-
went cataract extraction and intraocular lens insertion
after intraocular pressure lowering. Apart from visual
acuity and intraocular pressure (IOP), RNFL thickness
and vertical cup disc ratio (VCDR) were measured by
optical coherence tomography (OCT) at 3–9 months
post attack. Humphrey visual field assessment was
performed at 9 months post attack. All cases had mean
phacomorphic duration of \5 days. Postoperatively,
best correct Snellen visual acuity was 0.4 ± 0.2 and
IOP at 9 months was 11.0 ± 3.1 mmHg. There was no
difference in VCDR and RNFL between the attack
and contralateral eye at 3 months post attack (both
p = 0.4). At 9 months post attack, there was significant
thinning in the average (p = 0.01), superior (p = 0.01),
and inferior (p = 0.006) RNFL. There was no
significant difference in the pattern standard deviation
(PSD) between the two eyes on the Humphrey visual
field nor was there any correlation between PSD
severity and RNFL thinning (all p[0.2. Patients with
\5 days duration of phacomorphic angle closure are
likely to have reasonable postoperative vision. An
acute episode of phacomorphic angle closure can
trigger an accelerated RNFL thinning despite normal
IOP and open angles, most noticeable in the superior
and inferior quadrants, occurring between 3 and 9
months post attack. Glaucomatous optic neuropathy in
the attack eye was evident by OCT but not by visual
field assessment at the same time interval.
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Introduction
Phacomorphic angle closure is a secondary angle
closure caused by a swollen and mature cataract
obstructing the drainage angle, leading to an acute
elevation of intraocular pressure (IOP) and potential
glaucomatous optic neuropathy (GON) if not treated
timely. The initial aim of treatment of phacomorphic
angle closure is to lower the IOP with combinations of
topical anti-glaucoma medications, systemic acetazol-
amide, intravenous mannitol and or argon laser
iridoplasty (ALPI) [1]. All of these treatments have
been established to be effective initial treatments with
no evidence showing superiority of one over the other
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at the moment. The definitive treatment after IOP
control is cataract extraction.
The term phacomorphic glaucoma is used if there
resultant GON [1] which has been previously quanti-
fied and reported using visual field (VF) assessments or
clinical cup-disc ratio monitoring. However, both of
these parameters are variable and not entirely objective
especially when phacomorphic angle closure often
affects an elderly population where dementia and
neglect are common [2]. In addition, studies in acute
primary angle closure (APAC) have shown that more
than half of the patients with a single attack can have no
visual field defects [3]. On the other hand, retinal nerve
fiber layer measurements can detect early GON as its
damage often precedes visual field loss [4]. The use of
optical coherence tomography (OCT) for retinal nerve
fibre layer (RNFL) and optic nerve head analyses is
non-invasive, requires minimal patient cooperation,
and provides objective and early assessment of GON in
patients with phacomorphic angle closure.
Purpose
To investigate the RNFL changes after an acute attack
of phacomorphic angle closure.
Patients and methods
Consecutive cases of acute phacomorphic angle
closure from December 2009 to December 2010 were
recruited from Caritas Medical Center, Hong Kong
Special Administrative Region, People’s Republic of
China. Patient’s intraocular pressure was lowered
initially either by ALPI or systemic acetazolamide.
The selection between the two initial treatments was
randomized. The randomization was part of a treat-
ment protocol of another study comparing the effects
of initial treatments in phacomorphic angle closure.
Those receiving ALPI received laser applications 360
to the peripheral iris with power titrated to achieve
visualized contractions of the iris. All ALPI was
performed by a single surgeon (JL). Those receiving
systemic acetazolamide received intravenous aceta-
zolamide 500 mg stat followed by oral acetazolamide
250 mg four times daily and slow-release potassium
chloride tablets 600 mg twice daily if there were no
systemic contraindications. All patients were put on
the following eye drops: Atropine 1 % daily (Alcon
Inc., Hu¨nenberg, CH-6331, Switzerland), Pred
forte1% four times daily (Allergan Inc., Irvine, CA
92623-9534, USA), and Timolol 0.5 % twice daily
(Santen Pharmaceutical Co. Ltd., Osaka, 533-8651,
Japan) in the attack eye. Patients with presenting IOP
higher than 60 mmHg or IOP higher than 40 mmHg
after 2 h of treatment were given 200 ml of 20 %
mannitol intravenously over 1 h. Hourly IOP was
documented until it was below 25 mmHg.
Cases were included for consenting individuals
with a first episode of acute (\14 days) phacomorphic
angle closure with an IOP more than 40 mmHg. The
diagnosis of phacomorphic angle closure was based on
the presence of an intumescent cataract and signs of
acute angle closure: conjunctival injection, shallow
anterior chamber, corneal edema in the index eye or an
open angle in the contralateral eye as determined by
gonioscopy [2]. Cases were excluded if IOP lowering
treatment was given for this acute episode prior to the
study or where ALPI was not possible either due to a
severely edematous cornea or uncooperative patient.
All cases received extracapsular cataract extraction
(ECCE) and intraocular lens (IOL) insertion under
regional anesthesia by one of the three glaucoma
surgeons at our center within 3 days of presentation to
our clinic. All glaucoma medications were discontin-
ued immediately after the cataract extraction. ECCE
was chosen over phacoemulsification due to less
endothelial damage from ultrasound energy and
phacoemulsification would impose greater surgical
risk in the setting of phacomorphic angle closure
especially in the presence of any residual corneal
edema and zonule loosening [2].
Patients were followed up on day one, 1 week, 1
month, 3 months and as needed postoperatively and
IOP was measured by Goldman applanation tonom-
etry in each visit. Best corrected visual acuity (BCVA)
was measured by Snellen chart at 1 month postoper-
atively. The trabecular-iris angle was measured by
gonioscopy and ultrasound biomicroscopy (UBM) at 3
months post attack.
Stratus optical coherence tomography (Carl Zeiss
Meditec Inc., Dublin, CA, USA) was used for RNFL in
micrometers (lm) and vertical cup-disc ratio (VCDR)
measurements in both eyes at 3 and 9 months post
phacomorphic attack. The pupils were pharmacologi-
cally dilated to at least 5 mm prior to OCT and all scans
were performed using fast scan mode by a single operator
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(JL) with 4 years of operating experience. All scans had
centered alignment and signal strength of six or more,
suboptimal scans were repeated. Multiple scans (two to
four per eye) were obtained per secession and the scan
with the highest quality (highest signal strength and most
centred alignment) was selected.
Visual field was assessed at 9 months post cataract
extraction with the Humphrey Field Analyzer (Carl
Zeiss Ophthalmic Systems, Inc., Dublin, CA, USA)
using Swedish interactive threshold algorithm fast
(SITA Fast), 24-2 strategy.
Statistics
Paired Wilcoxon matched pairs (signed rank) test was
used to compare the RNFL in the following settings:
(1) Between the eye with phacomorphic angle
closure and the contralateral (non-attack) eyes
at 3 months.
(2) Between the eye with phacomorphic angle
closure at 3 and 9 months.
(3) Between the contralateral eye at 3 and 9 months.
For the above tests, the four quadrants and average
thickness were compared independently in a planned
comparison basis.
Mann–Whitney U test was used to compare the
RNFL and VCDR between eye with phacomorphic
angle closure and contralateral eye as well as to
compare the pattern standard deviation (PSD) on the
VF between the two eyes. Pearson’s correlation was
used to determine correlation between RNFL and PSD.
For all statistical calculations p \ 0.05 was
considered significant and all means were presented
as mean ± standard deviation.
The institutional review board of the Hospital
Authority of Hong Kong approved this study. The
study protocol followed the principles in the Decla-
ration of Helsinki. Informed consent was obtained
from all patients prior to all treatments and investiga-
tions. The authors declare no proprietary interest or
financial sponsorship.
Results
Eleven consecutive cases of acute phacomorphic angle
closure presented to our center during the study period.
One case was later excluded because of defaulting
follow-up after cataract extraction. Four cases received
ALPI and six cases received systemic acetazolamide as
the initial means of control IOP. All IOP’s were lowered
to\25 mmHg within 5 h of treatment with corneal clarity
achieved day one after treatment. Two cases received
intravenous mannitol because one presented with IOP
more than 60 mmHg and the other had persistent IOP[40
mmHg 2 h after treatment with systemic acetazolamide.
There were no systemic side effects of mannitol. All
cases received ECCE ? IOL within 3 days of presenta-
tion to our center. There were no intra-operative
complications. One case required scleral fixation of the
IOL due to postoperative posterior chamber IOL sublux-
ation 1 week after the initial operation. None of the cases
had any documented history of ocular trauma.
For the ten cases, the mean age was 79.1 ± 8.3
years. The presenting IOP was 50.5 ± 7.4 mmHg. The
mean time taken from phacomorphic symptoms to
ophthalmic consultation was 2.1 ± 2.8 days (range:
0.5–10 days). The postoperative IOP at 3 months was
10.5 ± 3.4 mmHg without any glaucoma medication.
At 9 months post operation, the mean IOP was 11.0 ±
3.1 mmHg; all except one patient required topical
glaucoma medications for IOP control \21 mmHg.
All cases had an open trabecular-iris angle configura-
tion on gonioscopy and UBM.
The presenting mode visual acuity was light percep-
tion (LP). The BCVA postoperative VA was 0.4 ± 0.2,
including a case was a pre-existing atrophic macula that
had a presenting VA of LP and a postoperative VA of
0.1. There was no significant difference between the
VCDR as measured by OCT in the attack (0.6 ± 0.2) and
contralateral eye (0.6 ± 0.1) (p = 0.4).
At 3 months post attack, there was no significant
difference between the average RNFL of the eye with
phacomorphic angle closure (95.1 ± 21.5 lm) and the
contralateral eyes (105.9 ± 27.8 lm) (p = 1.0).
Analyses of each of the individual quadrants again
showed no difference between the two eyes (all p[0.2).
However, at 9 months post attack, the average
RNFL of the phacomorphic eye had progressive
thinning from 95.1 ± 21.5 lm at 3 months to 85.4 ±
21.0 lm at 9 months (p = 0.01). Quadrant analyses
showed significant thinning in the superior (110.5 ±
32.74 to 95.9 ± 30.6 lm, p = 0.01) and inferior
quadrants (117.8 ± 30.7 to 90.60 ± 25.5 lm, p =
0.006) but there was no significant progressive thin-
ning in the nasal (p = 0.6) or temporal (p = 1.0)
quadrants (Tables 1, 2).
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For the contralateral eye, there was no significant
difference in the average RNFL (p = 0.1) nor
individual quadrants from 3 to 9 months (all p[0.2).
Six cases were able to produce reliable Humphrey
visual field assessments. The other cases had poor
fixation, unreliable parameters or defaulted the appoint-
ment. The mean deviation (MD) was -5.8 ± 3.7 decibels
(db) and the PSD was 4.2 ± 3.0 db. There was no signif-
icant difference in the PSD between the attack (4.2 ±
3.0 db) and contralateral eye (3.1 ± 1.1 db) (p = 0.7).
There was also no significant correlation between the
RNFL thickness on OCT and the PSD on VF (p = 0.2).
Discussion
In the literature, OCT for RNFL has been used to
evaluate the damage after a single episode of acute
primary angle closure and to offer a more objective
supplement to the information provided by Humphrey
visual field assessments. To the best of our knowledge,
this is the first prospective clinical trial using OCT to
investigate RNFL thickness and VCDR in phacomor-
phic angle closure.
Various studies have associated poor visual outcomes
with a longer duration of phacomorphic symptoms. Lee
et al. [2] have found a linear relationship between a longer
duration of attack and a poorer VA. Ramakrishanan et al.
[5] found that 70 % of their phacomorphic glaucoma
patients had final BCVA of 20/40 when the duration of
symptoms was \10 days. Similarly, Prajna et al. [6]
found that 61 % of their phacomorphic patients had final
visual acuity of 6/12 or better but that a glaucomatous
process for more than 5 days was associated with poorer
visual outcome. Our study was consistent with these
finding in that our patients had a final mean BCVA of 0.4
± 0.2; their mean phacomorphic symptom duration was 2
days and all received definitive cataract extraction within
3 days of presentation, resulting in a mean duration of
phacomorphic angle closure of\5 days.
We have demonstrated that despite the definitive
removal of the intumescent cataract, glaucomatous
optic neuropathy was an ongoing progress that took
place between 3 and 9 months after the initial attack.
There was no significant RNFL difference between the
phacomorphic and contralateral eye at 3 months but a
significant thinning of the average, superior and
inferior RNFL was observed at 9 months post attack
in the eye with previous phacomorphic angle closure.
The contralateral eye, on the other hand, showed no
interval differences in the average or quadrant RNFL
thicknesses.
Studies involving APAC have used scanning laser
polarimetry to demonstrate that RNFL can be thinned
Table 1 RNFL thickness (lm) of the phacomorphic eye ver-








110.5 ± 32.7 121.5 ± 34.6 0.6
Nasal quadrant 71.1 ± 24.9 78.7 ± 24.7 0.3
Inferior
quadrant
117.8 ± 30.4 132.9 ± 23.3 0.2
Temporal
quadrant
76.3 ± 19.5 73.1 ± 14.4 1.0
Average
thickness
94.4 ± 22.6 102.6 ± 20.3 1.0












121.5 ± 34.6 115.8 ± 28.7 0.2 110.5 ± 32.7 95.9 ± 30.7 0.01*
Nasal
quadrant
78.7 ± 20.7 76.7 ± 15.8 0.5 71.1 ± 24.9 74.0 ± 20.2 0.6
Inferior
quadrant
132.9 ± 23.1 114.5 ± 31.2 0.4 117.8 ± 30.7 90.6 ± 25.5 0.006*
Temporal
quadrant
73.1 ± 14.4 91.9 ± 37.4 0.3 76.3 ± 19.5 80.7 ± 34.0 1.0
Average
thickness
102.6 ± 20.3 99.76 ± 17.8 0.1 94.4 ± 22.6 85.4 ± 21.0 0.01*
* Statistically significant (p \ 0.05)
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after the attack [7, 8]. But no study to date can
determine the rate of RFNL thinning after an episode
of APAC [9, 10]. Aung et al. [7] has found that RNFL
can decrease from anywhere between 2 and 16 weeks
after a primary angle closure attack. Similarly, Tsai
et al. [12] found no significant difference in RNFL
thinning between 4 and 12 weeks post APAC but
significant differences between 1 and 4, and 1 and 12
weeks. In fact, they found that the RNFL was thicker at
1 week in the eye with APAC compared the contra-
lateral eye followed by a rapid thinning by 4 weeks,
likely due to an initial optic nerve edema.
One may argue that the progressive RNFL thinning
in primary acute angle closure may not all be
attributed to the acute rise in IOP as this group of
patients will have had narrow drainage angles for a
certain duration and the RNFL thinning may represent
damage from previous intermittent angle closures or a
chronic angle closure in evolution. On the other hand,
in phacomorphic angle closure, the pathology is in the
sudden anterior bulging of the swollen cataract, thus,
intermittent or asymptomatic chronic angle closure is
less likely than in APAC. Thus, the GON that allows a
phacomorphic attack is possibly mainly attributed to
the acute IOP rise. Yoles and Schwartz [13] have
suggested that GON progression can occur even after
elimination of the acute rise in IOP as a result of
secondary apoptosis of healthy neurons bathed in the
degenerative milieu created by the damaged neurons
from the acute event.
The other possibility for GON progression is a
secondary angle closure that develops after the
phacomorphic attack but all our cases had IOP \ 21
mmHg during follow-up and the mean IOP at 9
months was 11.0 ± 3.1 mmHg with open angle
configurations on UBM. Therefore, we are more
inclined with the postulation that the initial optic nerve
hypoperfusion from the phacomorphic attack induced
cellular inflammatory cytokines and free radicals that
led to progressive ganglion cell damage even after the
initial phacomorphic angle closure resolved. It is also
possible that there can be some initial optic nerve
edema post attack that gradually subsides with time
giving the impression of a ‘‘pseudo-thinning’’ but our
first OCT was performed quite some time after the
initial attack, at 3 months post operation, and by
comparison with the contralateral eye, there was no
significant difference in thickness, making this possi-
bility less likely. Our study involving secondary angle
closure reports RNFL thinning between 3 and 9
months post attack and our follow-up OCT is one of
the longest reported in literature for acute angle
closure.
Regarding the use of VF in the assessment post
phacomorphic angle closure, a number of patients
lacked the coordination to produce a reliable VF.
Furthermore, the results produced at 9 months post
attack failed to demonstrate any significant difference
between the phacomorphic and contralateral eye but
there was already significant RNFL thinning detected
on OCT. There was also no correlation between the
PSD on VF and the degree of RNFL thinning on OCT.
This study had its limitations. First, the assumption
was made that both eyes had similar initial RNFL
thickness and VCDR prior to the phacomorphic attack
when using the contralateral eye as a proxy of the pre-
phacomorphic state. This was because all of the cases
presented to our center for the first time during the
attack without any prior clinical data. It is possible that
the documented RNFL thinning may be due to an
underling normal tension glaucoma per se, therefore,
in addition to comparing with the other eye, we also
compared the progression of RNFL thinning in
contralateral eye as well at 3–9 months and only
found progression in the attack eye but not in the
contralateral eye. Second, both ALPI and medical
treatment was used to lower IOP but there is no
evidence in the literature to support superiority of one
treatment over the other and all IOP’s were lowered to
25 mmHg within 5 h of presentation. Our study further
supports this evidence that the initial IOP lowering
technique was not related to outcomes.
Conclusion
In our prospective case series, patients with \5 days
duration of phacomorphic angle closure had a mean
Snellen vision of 0.4. An acute episode of phacomor-
phic angle closure can trigger an accelerated thin-
ning of the average RNFL occurring between 3 and
9 months post phacomorphic attack despite normal
IOP and open angles. The RNFL thinning was most
prevalent in the superior and inferior quadrants as
detected by OCT whilst visual field assessment failed
to detect any significant differences between the attack
and uninvolved eye.
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